Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION CONTAINING GLP-1 RECEPTOR AGONIST ANALOG
Document Type and Number:
WIPO Patent Application WO/2024/017139
Kind Code:
A1
Abstract:
The present invention provides a pharmaceutical composition, comprising a GLP-I receptor agonist or an analog thereof, and further comprising one or more of the following components: a pro-penetrating agent, a basic substance, and an adhesive material. The technology can not only greatly improve the bioavailability and solve the problem of a low response rate for patients, but also is expected to solve the problem of low administration compliance of previous marketed medicines; and the prescription process is simple and stable, and production and transportation are convenient.

Inventors:
TANG SHAN (CN)
HUANG YIJUAN (CN)
BAO SHA (CN)
LIU TAO (CN)
LIU YINKUN (CN)
Application Number:
PCT/CN2023/107299
Publication Date:
January 25, 2024
Filing Date:
July 13, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHENGDU HYPERWAY PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K45/00; A61K9/20; A61K9/48; A61K38/26; A61P3/10; C07K14/605
Domestic Patent References:
WO2021219543A12021-11-04
WO2018121702A12018-07-05
Foreign References:
US20210353718A12021-11-18
CN104740647A2015-07-01
US20130345134A12013-12-26
US20190060410A12019-02-28
Attorney, Agent or Firm:
CHENGDU HUAFENG PATENT OFFICE (GENERAL PARTNERSHIP) (CN)
Download PDF: